Supporting Evidence-Based Decisions About Pneumococcal Conjugate Vaccines

Results of recent studies that we supported focusing on vaccination against Streptococcus pneumoniae, a Gram-positive bacterium that is responsible for the majority of community-acquired pneumonia, were recently published, providing more evidence for health departments to use when developing their pediatric vaccination strategies.

Continue ReadingSupporting Evidence-Based Decisions About Pneumococcal Conjugate Vaccines

The Colors of COVID Town Hall Event: The Ethical Engagement of Minority Communities in COVID Clinical Research

In April, the Director of the Maryland Center for Health Equity’s Dr. Stephen B. Thomas partnered with FHI Clinical for a frank conversation by experts about COVID and how to encourage Brown and Black communities to participate in clinical research.

Continue ReadingThe Colors of COVID Town Hall Event: The Ethical Engagement of Minority Communities in COVID Clinical Research

A Unique Public-Private Partnership to Eradicate Malaria in Equatorial Guinea: Part 2 of the ASTMH Blog Series

One example of the ability of public-private partnerships to establish and strengthen research capacity is the Equatorial Guinea Malaria Initiative (EGMVI), which began within the larger Bioko Island Malaria Control Project (BIMCP). Last year, the two were combined into the Bioko Island Malaria Elimination Project (BIMEP). Dr Stephen Hoffman from Sanaria, Inc. shared details of the BIMEP with us at FHI Clinical’s ASTMH dinner event. FHI Clinical has also had the privilege of being involved in studies conducted by the EGMVI (now BIMEP).

Continue ReadingA Unique Public-Private Partnership to Eradicate Malaria in Equatorial Guinea: Part 2 of the ASTMH Blog Series

Providing Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea

Data monitoring strategies implemented by our bilingual CRA helped eliminate the backlog to ensure timely database lock in a phase 2 trial for Sanaria's innovative PfSPZ Vaccine for malaria in Equatorial Guinea, an area with limited prior research experience.

Continue ReadingProviding Site Monitoring and Management Expertise in Malaria Vaccine Trials in Equatorial Guinea

Ebola Vaccination and Containment in the Democratic Republic of the Congo: What are the Challenges?

The Democratic Republic of Congo (DRC) is currently experiencing the world’s second-largest Ebola outbreak. Despite a coordinated vaccination and containment effort that began in August 2018, cases continue to occur and spread. As with other disease outbreaks in limited-resource countries, numerous factors have challenged the Ebola health care response in the DRC.

Continue ReadingEbola Vaccination and Containment in the Democratic Republic of the Congo: What are the Challenges?